Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 286,799 | 319,558 | 389,874 | 271,191 | 246,909 |
| Cost of Goods | 31,644 | 32,378 | 35,304 | 42,465 | 29,888 |
| Gross Profit | 255,155 | 287,180 | 354,570 | 228,726 | 217,021 |
| Operating Expenses | 199,708 | 204,371 | 190,127 | 199,123 | 183,770 |
| Operating Income | 56,091 | 83,187 | 164,747 | 30,068 | 34,139 |
| Interest Expense | 108 | 167 | 85 | 55 | 34 |
| Other Income | 3,142 | 2,347 | 2,300 | 4,479 | 5,885 |
| Pre-tax Income | 59,125 | 85,367 | 166,962 | 34,492 | 39,990 |
| Income Tax | 4,565 | 9,022 | 24,272 | 7,516 | -27,388 |
| Net Income Continuous | 54,560 | 76,345 | 142,690 | 26,976 | 67,378 |
| Minority Interests | -61 | 128 | 7,492 | 147 | 93 |
| Net Income | $54,621 | $76,217 | $135,198 | $26,829 | $67,285 |
| EPS Basic Total Ops | 0.54 | 0.75 | 1.34 | 0.26 | 0.67 |
| EPS Basic Continuous Ops | 0.54 | 0.75 | 1.42 | 0.27 | 0.67 |
| EPS Diluted Total Ops | 0.52 | 0.73 | 1.30 | 0.26 | 0.66 |
| EPS Diluted Continuous Ops | 0.52 | 0.73 | 1.37 | 0.26 | 0.66 |
| EBITDA(a) | $83,953 | $113,130 | $191,438 | $78,308 | $58,037 |